James Huang
CIK 1573160 · Chief Executive Officer · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$31.90M
Companies
7
Total Filings
44
Lifetime Open-Market Net
$8.60M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CNTB | Director | 13,310,000 | $2.12 | $28.22M | $4.37M | 2 | 2026-06-02 |
| ATRA | Director | 307,894 | $10.41 | $3.21M | -$4.99M | 3 | 2026-05-11 |
| TCRT | Director | 188,333 | $2.26 | $425.6K | $0 | 3 | 2023-06-08 |
| WINT | Director | 3,745,442 | $0.01 | $53.9K | $7.73M | 17 | 2023-02-23 |
| CASI Pharmaceuticals, Inc. (CASI) Delisted | Director | 371,708 | $0.28 | $104.1K | $1.32M | 14 | 2022-09-08 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Director | 108,333 | $0.87 | $93.8K | $171.0K | 3 | 2021-09-03 |
| CASI Pharmaceuticals, Inc. (ENMD) Delisted | Director | — | — | — | $0 | 1 | 2013-05-31 |
Recent Filings · Page 3 of 5
44 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-06 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Grant (A) | +8,333 | $0 | EDGAR |
| 2021-04-02 | WINT | Buy (P) | +150,000 | $354.0K | EDGAR |
| 2021-02-05 | WINT | Grant (A) | — | $0 | EDGAR |
| 2020-10-27 | WINT | Buy (P) | +1,000 | $6.7K | EDGAR |
| 2020-10-26 | WINT | Buy (P) | +12,000 | $87.9K | EDGAR |
| 2020-07-22 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-18 | CASI Pharmaceuticals, Inc. (CASI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-05 | WINT | Buy (P) | +12,400 | $90.8K | EDGAR |
| 2020-05-27 | WINT | Buy (P) | +275,862 | $2.00M | EDGAR |
| 2020-02-20 | WINT | Buy (P) | +400 | $1.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.